NMR
Lifespin Taps Biobank Graz, Medical University of Graz for Oncology Patient Samples
Lifespin will gain access to more than 25,000 blood samples from roughly 4,800 cancer patients that it will analyze using its metabolomics platform.
Metabolomics Data Company Lifespin Closes €2.5M Bridge Financing Round
The firm intends to use the funding to continue the development of its proprietary artificial intelligence-based testing platform to measure metabolomic data.
Numares, Oxford University Ink License Agreement to Develop Multimarker Multiple Sclerosis Test
Numares will develop the MS test to detect the transition from relapsing remitting multiple sclerosis to secondary progressive multiple sclerosis.
The German company is focused on cancer and neurology and aims to bring its initial tests to the US and European markets in the next two years.
Numares Collaborating With Bruker on NMR-Based Diagnostics
The company aims to transition its NMR-based platform from research to clinical use and is exploring areas including kidney and liver disease and neurology.